These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 582449)

  • 21. [Treatment of diffuse hyperthyroidism using radioactive iodine].
    Latković I; Krpan N; Simonović I
    Lijec Vjesn; 1975 Feb; 97(2):72-7. PubMed ID: 1174256
    [No Abstract]   [Full Text] [Related]  

  • 22. [Experience with ambulatory radioiodine therapy of hyperthyroidism].
    Róka R; Séra T; Valkusz Z; Julesz J; Csernay L; Pávics L
    Orv Hetil; 1999 Jun; 140(23):1291-5. PubMed ID: 10412264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Dosimetry in hepato-biliary "in vivo" with thermoluminescent detectors. 3. Results of the use of I 131-rose bengal radioisotope diagnosis].
    De Maria M; De Simone GF; Latteri M; Bajardi G; Castiglione C
    Minerva Med; 1980 Jun; 71(24):1709-11. PubMed ID: 7413102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radioactive iodine therapy in Graves' hyperthyroidism: a prospective study from a tertiary referral centre in north India.
    Sankar R; Sekhri T; Sripathy G; Walia RP; Jain SK
    J Assoc Physicians India; 2005 Jul; 53():603-6. PubMed ID: 16190128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Excess radiation absorbed doses from non-optimised radioiodine treatment of hyperthyroidism.
    Jönsson H; Mattsson S
    Radiat Prot Dosimetry; 2004; 108(2):107-14. PubMed ID: 14978290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of nuclear medicine in the management of Graves' disease.
    Freitas JE
    Q J Nucl Med; 1999 Dec; 43(4):297-306. PubMed ID: 10731780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Airway complication occurring during radioiodine treatment for Graves' disease.
    Kinuya S; Yoneyama T; Michigishi T
    Ann Nucl Med; 2007 Aug; 21(6):367-9. PubMed ID: 17705018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Direct dose confirmation of quantitative autoradiography with micro-TLD measurements for radioimmunotherapy.
    Griffith MH; Yorke ED; Wessels BW; DeNardo GL; Neacy WP
    J Nucl Med; 1988 Nov; 29(11):1795-809. PubMed ID: 3263479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose].
    Bakker SC; Zanin DE; Zweers EJ
    Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1837-41. PubMed ID: 12382370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The treatment of hyperthyroidism with and indication for radioactive iodine].
    Klokke AR; van der Vijver JC
    Ned Tijdschr Geneeskd; 1995 Apr; 139(16):819-21. PubMed ID: 7537352
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment of hyperthyroidism in adolescents with radioactive iodine].
    Górowski T; Kaniewski M
    Pol Tyg Lek; 1980 Aug; 35(33):1269-70. PubMed ID: 6893627
    [No Abstract]   [Full Text] [Related]  

  • 32. Low-dose 131I fails to hold euthyroidism in Graves' cases.
    Hosp Pract (Off Ed); 1983 Oct; 18(10):40-1. PubMed ID: 6413375
    [No Abstract]   [Full Text] [Related]  

  • 33. Administration of additional inactive iodide during radioiodine therapy for Graves' disease: who might benefit?
    Dietlein M; Moka D; Reinholz U; Schmidt M; Schomäcker K; Schicha H; Wellner U
    Nuklearmedizin; 2007; 46(3):77-84. PubMed ID: 17549318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparisons of sectioned micro-TLD dose measurements with predicted dose from 131I-labeled antibody.
    Langmuir VK; Wessels BW; Mendonca H; Yorke ED; Montilla L
    Med Phys; 1992; 19(5):1213-6. PubMed ID: 1435601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation of stress with outcome of radioiodine therapy for Graves' disease.
    Stewart T; Rochon J; Lenfestey R; Wise P
    J Nucl Med; 1985 Jun; 26(6):592-9. PubMed ID: 3839012
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Characterization of therapy failures in radioiodine therapy of Graves' disease without simultaneous antithyroid agents].
    Sabri O; Zimny M; Schreckenberger M; Reinartz P; Nowak B; Ostwald E; Schäfer W; Block S; Setani K; Büll U
    Nuklearmedizin; 2001 Feb; 40(1):1-6. PubMed ID: 11373933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Radioiodine therapy of autonomously functioning thyroid nodules and Graves' disease].
    Guhlmann CA; Rendl J; Börner W
    Nuklearmedizin; 1995 Feb; 34(1):20-3. PubMed ID: 7724360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The low occurrence of clinically significant ophthalmopathy after ablative treatment with radioactive iodine for Graves' hyperthyroidism.
    Ureles AL; Cronmiller JR
    J Nucl Med; 1993 Oct; 34(10):1829. PubMed ID: 8410313
    [No Abstract]   [Full Text] [Related]  

  • 39. Radiation dosimetry for the adult female and fetus from iodine-131 administration in hyperthyroidism.
    Stabin MG; Watson EE; Marcus CS; Salk RD
    J Nucl Med; 1991 May; 32(5):808-13. PubMed ID: 2022987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radioiodine (131I) treatment of hyperthyroidism: radiation protection and quality assurance.
    Reiners C; Lassmann M
    Eur J Nucl Med; 1999 Jul; 26(7):683-5. PubMed ID: 10398814
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.